Objective: Characterization and structure elucidation of the degradation products which resulted from the acidic hydrolysis of lisinopril under drastic condition. Method: Ultra-performance liquid chromatography coupled with mass/mass spectroscopy (LC-MS/MS) with simple and sensitive method was used to detect the formed degradation products. The fragmentation patterns of the degradation products were investigated. Results: The validation of analytical method was satisfied to the recommend criteria of international conference of harmonization. Four degradation products were formed due to the acidic hydrolysis of lisinopril. Conclusion: Two degradation products were described in E. Ph. 
INTRODUCTION

Lisinopril,2S)-1-[(2S)-6-amino-2-{[(1S)-1-carboxy-3-phenylpropyl
] amino}hexanoyl] pyrrolidine-2 carbo-xylic acid is an angiotensin converting enzyme (ACE) inhibitor, used for the treatment of hypertension, heart failure, and acute myocardial infarction [1] [2] . A wide variety of separation and detection techniques have been applied to the analysis of lisinopril, such as gas chromatography coupled with mass spectrometry (GC/MS) [3] [4] , high performance liquid chromatography (HPLC) [5] [6] , and high performance liquid chromatography coupled with mass spectrometry (HPLC/MS) [7] [8] . The degradation profile of a drug substance is critical to its safety assessment and formulation process in addition to dosage form administration. For safety reasons, the degradation products or impurities of a drug that exceed 0.1% must be identified prior to clinical trials 9 . This paper presents a modified validated method for determination of lisinopril with high resolving from the formed degradation products or impurities by LC-MS/MS in addition to identification of the four formed degradation products by employing LC-MS/MS analysis technique and studying the fragmentation behavior of the resulted product ions to elucidate their chemical structures.
MATERIALS AND METHODS
Materials
Lisinopril certified reference standard (CRS), USA Pharmacopeia, USA. Lisinopril raw material was purchased from Sigma aldrish, Germany. Formic acid was from Sharlu, Spain; Acetonitrile and methanol HPLC grade were brought from J. T. Baker, USA. All other reagents were of analytical grade. Distilled
Method
Preparation of mobile phase
The mobile phase was prepared according to Zhou et al., 10 with a slight modification in its composition (aqueous to organic ratio) to resolve lisinopril and degradation products. It consists of an acidified aqueous solution with formic acid (pH 2.9): methanol: acetonitrile in a ratio of (75: 15: 10, v/v), respectively. The mixture was stirred continuously for 30.0 min to ensure complete equilibrium. The final mobile phase solution was filtered on 0.2µm millipore filtration system and degassed on ultra-sonicator path for 20.0 min to get rid of air bubbles.
Preparation of serial standard solutions
A stock solution was prepared by dissolving a respective weight of Lisinopril CRS in mobile phases to obtain a concentration of 5µg/ml. Serial concentrations of 50, 100, 150, 200, 250,300 and 350 ng/ml were prepared from the stock solution to construct a calibration curve.
Preparation of sample solutions
Serial concentrations of sample solutions were skipped with 50 ng/ml of lisinopril standard solution to obtain concentrations of 150, 200 and 250 ng/ml.
Acidic hydrolysis of lisinopril
Lisinopril solutions of 50 µg/ml concentration were exposed to acidic hydrolytic degradation under the effect of 0.1 N HCl for 4 h at a temperature of 90°C. At the end of the experimental period, the solutions were diluted with the mobile phase and filtered through 0.2µm membrane to be injected into LC-MS/MS.
Validation of the analytical method
Validation of the analytical method was performed according to the international conference of harmonization guidelines (ICH) 11 for terms of linearity, accuracy, range, precision, specificity, sensitivity, and robustness and governed by United States pharmacopeia [USP 38 NF 29] 12 criteria for chromatographic separation.
Identification of the degradation products using LC-MS/MS
LC-MS/MS was employed for characterization of the degradation products 13 resulting from exposure of lisinopril to drastic hydrolysis conditions. First; the study was based on injecting lisinopril standard solution at concentration 200 ng/ml into LC-MS/MS system for determining the relative standard deviation percentage %RSD to confirm the precision and integrity of LC-MS/MS system conditions. Second; the study was extended to determine and follow the fragmentation pattern pathway of the degradation products which formed under the effect of acidic hydrolysis conditions of 0.1N HCl at temperature 90 °C for 4 h on lisinopril molecule. Three replicates were obtained from the acidic hydrolysis of lisinopril and diluted with the mobile phase, filtered through 0.2 µm membrane filter and injected in duplicates into the LC-MS/MS system. Ion transition of screen spectrum was applied to m/z 1000 to detect the main separated degradation products and subsequently followed by running the spectrum to m/z 600 for every degradation product. The collision energy in a range of 10-35v at a fixed cone value was screened for every degradation product to select the appropriate value, which enables the detection of the fragment ions with accepted relative abundance value for degradation products characterization.
RESULTS AND DISCUSSION
Validation of the analytical method Table 1 by LC-MS/MS which revealed a high linear calibration curve as represented by Figure 1 at a range between 50-350 ng/mL with mean recovery 99.93% of SD ± 0.42 for the spiked samples. The precision of the method evaluated by means of the relative standard deviation percentage (%RSD) of intraday ruggedness between two analysts at three different times per day (morning, noon, evening) was 0.29 and % RSD inter-day ruggedness between two analysts at three successive days was 0.74. The sensitivity of the method was represented by limit of detection 9.38 ng/ml and limit of quantitation 28.43ng/ml. The method is robust and can tolerate different labs variations according to robustness studies results. Specificity of the method to separate lisinopril from its degradation products was achieved with resolving of lisinopril from its degradation products with resolution factor of 3.28. System suitability of the validated method was accepted as described in Table 2 . Studying the fragmentation pattern of lisinopril and its degradation products LC-MS/MS could identify the degradation products of lisinopril by studying its fragmentation patterns represented by the mass spectrum [14] [15] . Table 4 . Table 6 . Table 7 and Figure  14 . From the previous studying of the fragmentation pattern pathways and schematic analysis of the degradation products resulted from the acidic hydrolysis of lisinopril, it was found that four main degradation compounds were formed as summarized in the 
